CTOs on the Move

Onyx Pharmaceuticals

www.onyx.com

 
At Onyx Pharmaceuticals, an Amgen subsidiary, our imperative is to build a leading cancer therapeutics company like no other, working toward a unified goal that drives us forward…to deliver breakthrough cancer treatments to patients with the urgency they deserve.   By working in collaboration with patient advocacy groups, healthcare providers and business partners, we push the boundaries of science and cancer therapeuticdevelopment.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.onyx.com
  • 249 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.266.0000

Executives

Name Title Contact Details

Similar Companies

Kleo

Kleo Pharmaceuticals is advancing the field of immunotherapy by developing small molecules that emulate biologics.

Horizon Pharma

At Horizon Therapeutics, we believe science and compassion must work together to transform lives. We are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. For us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.

Enveric Biosciences

Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.

CareMount Medical

We have a number of positions available in our modern medical offices conveniently located at 90 and 110 South Bedford Road in Mount Kisco, as well as openings in our off-site offices in Yorktown, Katonah, Carmel, Fishkill, Poughkeepsie, Somers, Mahopa...

Circassia

Circassia Pharmaceuticals is a specialty biopharmaceutical company developing a range of immunotherapies.